We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PB:NYSEProsperity Bancshares, Inc. Analysis

Data as of 2026-07-19 - not real-time

$73.49

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Prosperity Bancshares is trading at roughly $73.5, comfortably above its 20‑day, 50‑day and 200‑day moving averages, indicating a sustained bullish trend. The RSI of 57 and a bullish MACD histogram reinforce this momentum while the price sits near a solid support level around $69.8 and below a near‑term resistance of $75. Valuation metrics suggest the stock is undervalued – a trailing P/E of 13.3 is well below the industry average of 17.8 and the DCF‑derived fair value of $87.6 implies about 8% upside. Fundamentally, the bank delivers strong profitability with an operating margin above 55% and a profit margin of 40%, and revenue growth close to 20% year‑over‑year. The dividend yield of 3.2% and a payout ratio under 45% point to a sustainable income stream, while low beta (≈0.5) and moderate 30‑day volatility (≈21%) keep price swings in check. Recent corporate announcements confirm the completion of a strategic initiative in early July, providing additional confidence in the company’s execution capability. Overall, the combination of technical strength, attractive valuation, solid earnings growth and a reliable dividend makes PB a compelling candidate for investors seeking a blend of growth and income.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical setup with price above key moving averages
  • Attractive dividend yield and sustainable payout
  • Undervalued relative to peers offering near‑term upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high operating margins
  • DCF fair value indicating upside potential
  • Low beta and moderate volatility supporting price stability

Long Term

> 3 years
Neutral
Model confidence: 8/10

Key Factors

  • Consistent dividend payments with sustainable coverage
  • Stable regional market position and low geographic concentration risk
  • Solid balance sheet with ample cash relative to debt

Key Metrics & Analysis

Financial Health

Revenue Growth19.90%
Profit Margin40.35%
P/E Ratio13.3
ROE6.73%
ROA1.28%
P/B Ratio0.9
Op. Cash Flow$556.5M
Industry P/E17.8

Technical Analysis

TrendBullish
RSI57.1
Support$69.79
Resistance$75.00
MA 20$72.46
MA 50$70.50
MA 200$69.20
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91

Valuation

Fair Value$87.57
Target Price$79.62
Upside/Downside8.33%
GradeUndervalued
TypeBlend
Dividend Yield3.24%

Risk Assessment

Beta0.50
Volatility21.64%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.